Bulletin
Investor Alert

New York Markets Open in:

Century Therapeutics Inc.

NAS: IPSC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 2, 2023, 5:50 p.m.

/zigman2/quotes/210490648/composite

$

4.58

Change

-0.06 -1.29%

Volume

Volume 15,381

Quotes are delayed by 20 min

/zigman2/quotes/210490648/composite

Previous close

$ 4.52

$ 4.64

Change

+0.12 +2.65%

Day low

Day high

$4.49

$4.68

Open

52 week low

52 week high

$4.34

$15.38

Open

Company Description

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It engages in harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi ...

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It engages in harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Valuation

Price to Book Ratio

2.20

Enterprise Value to EBITDA

-0.76

Enterprise Value to Sales

14.71

Efficiency

Liquidity

Current Ratio

14.57

Quick Ratio

14.57

Cash Ratio

14.24

Profitability

Return on Assets

-33.27

Return on Equity

-38.22

Return on Total Capital

-34.62

Capital Structure

Total Debt to Total Assets

5.74

Officers and Executives

Name Age Officer Since Title
Mr. Joseph Jimenez 60 2019 Director
Dr. Osvaldo Flores - - Chief Executive Officer & Director
Dr. Adrienne Farid 59 2021 Chief Operations Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/09/2022 Versant Venture Management LLC
364,800   0
08/09/2022 Versant Venture Management LLC
550,000   Disposition at $13.03 per share. 7,166,500
01/31/2022 Versant Venture Management LLC
178,996   0
12/23/2021 Versant Venture Management LLC
371,004   0
06/22/2021 Bayer AG
750,000   Acquisition at $20 per share. 15,000,000
06/22/2021 Versant Venture Management LLC
100,000   Acquisition at $20 per share. 2,000,000
06/22/2021 Eli Casdin
Director
750,000   Acquisition at $20 per share. 15,000,000
06/22/2021 Bayer AG
1,535,238   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Bayer AG
10,390,600   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Versant Venture Management LLC
614,095   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Versant Venture Management LLC
9,936,011   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 FUJIFILM Holdings Corp.
3,974,404   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Eli Casdin
Director
2,456,380   Derivative/Non-derivative trans. at $0 per share. 0
/news/latest/company/us/ipsc

MarketWatch News on IPSC

  1. Chardan Research initiates coverage of Century Therapeutics with a buy rating and $19 price target

    10:28 a.m. Dec. 27, 2022

  2. Century Therapeutics started at overweight with $40 stock price target at J.P. Morgan

    6:15 a.m. July 13, 2021

    - Tomi Kilgore

  3. Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares

    4:19 p.m. June 18, 2021

    - Barron's Online

  4. Century Therapeutics sets IPO terms; to offer 10.6 mln shares priced at $18 to $20 each

    5:21 a.m. June 14, 2021

    - Ciara Linnane

/news/nonmarketwatch/company/us/ipsc

Other News on IPSC

  1. 10-Q: CENTURY THERAPEUTICS, INC.

    7:34 a.m. Nov. 10, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Athersys: Is Big Pharma Sleeping At The Wheel?

    10:43 p.m. Oct. 5, 2022

    - Seeking Alpha

  3. Century Therapeutics (IPSC) Investor Presentation - Slideshow

    8:41 a.m. Sept. 14, 2022

    - Seeking Alpha

  4. 10-Q: CENTURY THERAPEUTICS, INC.

    6:34 a.m. Aug. 11, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Century Therapeutics (IPSC) Investor Presentation - Slideshow

    7:42 a.m. July 1, 2022

    - Seeking Alpha

  6. 10-Q: CENTURY THERAPEUTICS, INC.

    6:37 a.m. May 16, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  7. Company Corporate Overview Presentation Apr 2022

    4:50 p.m. April 29, 2022

    - Seeking Alpha

  8. 10-K: CENTURY THERAPEUTICS, INC.

    4:04 p.m. March 17, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. What's Behind Bristol Myers Squibb's Latest Partnership?

    11:29 a.m. Jan. 22, 2022

    - Motley Fool

  10. Loading more headlines...

At a Glance

Century Therapeutics, Inc.

3675 Market Street

Philadelphia, Pennsylvania 19104

Phone

-

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

N/A

Net Income

$-95.82M

Employees

170.00

/news/pressrelease/company/us/ipsc

Press Releases on IPSC

  1. Loading more headlines...
Link to MarketWatch's Slice.